BIOHARVEST SCIENCES APPOINTS ASTRONAUT CHRIS HADFIELD TO THE BOARD OF ADVISORS

December 1, 2021

Hadfield’s expertise will lead BioHarvest’s expanded focus to include space biology

 VANCOUVER, CANADA, AND REHOVOT, ISRAEL, December 1, 2021 – BioHarvest Sciences Inc.(“BioHarvest” or the “Company”) (CSE: BHSC) has appointed renowned astronaut Chris Hadfield to its board of advisors as part of a drive to leverage its biotech technology platform to provide essential nutrition and active ingredients for space exploration and potential new settlements in space.

Hadfield brings 40 years of scientific experience to the Canadian-Israeli biotech firm, which has developed and patented a plant bio-cell technology, called BioFarming, capable of growing the active and beneficial plant based ingredients at industrial scale, without the need to grow the plant itself.

Chris’s unparalleled experience will help marry our plant cellular biology expertise with space science,” said BioHarvest CEO Ilan Sobel. “He is a great addition to our advisory board at this phase of our growth, and he’ll help us in our drive to be a global biotech leader.

BioHarvest’s BioFarming technology has the potential to efficiently produce primary metabolites such as premium proteins that are needed to provide required nutrition for humans to live in space. It can also produce antioxidant compounds with antioxidant activity that can help reduce human cellular stress and prevent damage caused by microgravity and ionizing radiation, which is a critical health challenge experienced by astronauts while in space.

Hadfield joined the BioHarvest board of advisors a few weeks after visiting the Company’s research and development laboratories in Rehovot, Israel.

BioHarvest’s proprietary platform technology has the potential to make a significant impact on the world as well as in bio-space science,” Hadfield said. “The company has built a world-class team of scientists, and I look forward to working with them, with my fellow advisors, to scale BioHarvest’s solution.

The Canadian-born reserve colonel is an astronaut, engineer, and RCAF pilot who has flown 3 space missions, done 2 spacewalks, and commanded the International Space Station. He was named the top test pilot in both the US Air Force and the US Navy, and served as NASA’s Director of Operations in Russia.

Hadfield is an adjunct professor at the University of Waterloo, an adviser to SpaceX and Virgin Galactic, and chair of the board of the Open Lunar Foundation. He also leads the Space stream at the Creative Destruction Lab tech incubator, and is co-creator and host of TV series on BBC and National Geographic, as well as a 4-time internationally best-selling author.

BioHarvest, which can produce red grape, olive, and pomegranate cells, recently announced that it has successfully grown coral-shaped clusters of Cannabis trichomes  in bioreactors as well (see news release dated August 19 and September 1, 2021). The company recently announced revenues of  USD 688K in the third quarter of 2021, representing 44% growth over the previous quarter, based on promising early demand of its flagship red grape-based VINIA® product (see news release dated October 5, 2021).

About BioHarvest Sciences Inc.

BioHarvest Sciences Inc. (CSE: BHSC) is a fast-growing Biotech firm listed on the Canadian Securities Exchange. BioHarvest has developed a patented bio-cell growth platform technology capable of growing the active and beneficial ingredients in fruit and plants, at industrial scale, without the need to grow the plant itself. This technology is economical, ensures consistency, and avoids the negative environmental impacts associated with traditional agriculture. BioHarvest is currently focused on nutraceuticals and the medicinal cannabis markets. Visit:www.bioharvest.com.

Our Blog

2024 CEO Letter to Shareholders

“Our goal is to accelerate the Botanical Synthesis movement that our team has wholly dedicated themselves to – driving forward innovation, our...

Read More

About BioHarvest Sciences Inc.

BioHarvest Sciences Inc. (CSE: BHSC) is a fast-growing Biotech firm listed on the Canadian Securities Exchange. BioHarvest has developed a patented bio-cell growth platform technology capable of growing the active and beneficial ingredients in fruit and plants, at industrial scale, without the need to grow the plant itself. BioHarvest is currently focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions, within two major business verticals – nutraceutical health and wellness products such as dietary supplements, and development of plant cell-based Active Pharmaceutical Ingredients (API’s) that focus on specific medical indications.

ABOUT BIOHARVEST SCIENCES INC.